Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Ronald M Benoit"'
Publikováno v:
Brachytherapy. 21:79-84
To evaluate our institutional outcomes utilizing Cs-131 prostate brachytherapy (PB) for the intermediate-risk (IR) group of prostate cancer patients.We reviewed a prospectively collected database of men treated with Cs-131 PB between 2006 and 2019. P
Autor:
Ryan P. Smith, Ronald M. Benoit, Joshua L. Rodríguez-López, Michael D. Schad, Ankur K. Patel, Sushil Beriwal, Christopher J. Houser, Zachary D. Horne
Publikováno v:
Brachytherapy. 20:859-865
Baseline intraprostatic calcification (IC) has been shown to be associated with a higher rate of biochemical recurrence (BCR) in men treated with iodine-125 prostate brachytherapy (PB). We evaluated this association in a cohort of men treated with ce
Publikováno v:
Brachytherapy. 19:298-304
Aims To report on the PSA outcomes in men undergoing prostate seed implant (PSI) with Cesium-131 at a single institution. Materials and Methods All patients who underwent prostate brachytherapy with Cesium-131 (131Cs) at our institution and had the p
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 3, Iss 3, Pp 115-120 (2011)
Purpose: To further define the bothersome lower urinary tract symptoms that occur after prostate brachytherapy(PB) by evaluating patient’s responses to the individual questions of the urinary portion of the Expanded Prostate CancerIndex Composite (
Externí odkaz:
https://doaj.org/article/a79cb83584644ce291a5e9afc243a189
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 104:622-630
There is limited long-term data on outcome and side effects of Cs-131 prostate brachytherapy and minimal patient-reported data on rectal bleeding with any isotope. We aimed to describe the incidence, prevalence, and predictors of late patient-reporte
Publikováno v:
Brachytherapy. 19(4)
This study evaluates acute patient-reported bowel quality of life (QOL) and rectal bleeding in prostate cancer patients treated with combination external beam radiation (EBRT), low-dose-rate brachytherapy (LDR-BT), and SpaceOAR.A retrospective review
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 98:1053-1058
Purpose Prostate brachytherapy as monotherapy or in combination with external beam radiation therapy (EBRT) represents a curative treatment option for men with prostate cancer. Of the radioactive isotopes approved for use in prostate brachytherapy, C
Autor:
Sushil Beriwal, Scott M. Glaser, Ronald M. Benoit, Goundappa K. Balasubramani, Ryan P. Smith, Michael J. Dohopolski
Publikováno v:
Brachytherapy. 16:330-341
Androgen suppression combined with elective nodal and dose-escalated radiation therapy recently demonstrated an improved biochemical failure-free survival in men who received external beam radiation therapy (EBRT) plus a brachytherapy boost (BB) comp
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e910-e911
Autor:
Sushil Beriwal, Ronald M. Benoit, A. Keller, Ria Mulherkar, Ryan P. Smith, Mohamed Abdelhakiem, Siddharth Ghanta
Publikováno v:
Brachytherapy. 20:S47